UArizona and local high school students are invited to visit the Thomas W. Keating Bioresearch and Bioscience Research Lab Buildings. Tours are tailored to topics that coincide with the interests of the students, providing them with a hands-on, real-world look at the topics they are learning in their textbooks.
Community members are invited to tour the Thomas W. Keating Bioresearch and Bioscience Research Lab Buildings. Scheduled guests can visit active laboratories and speak with researchers about their interdisciplinary approach to advancing science and improving health and life in the 21st century.
The Technology and Research Initiative Fund (TRIF) that helped launch BIO5 in 2001 continues to catalyzes effective, cross-disciplinary bioscience research and innovation at the University of Arizona. In the past 19 years, over $50M has been invested in building critical facilities and research services that UArizona researchers are leveraging today to quickly and robustly respond to the current COVID-19 crisis.
Based off work by BIO5 members Drs. Janko Nikolich-Žugich and Deepta Bhattacharya, a COVID-19 antibody test was developed and quickly deployed across the state to test first responders in early May. The same test will be available to all UArizona students, staff and faculty to work towards resuming in-person activities this fall.
A team of UArizona researchers including several BIO5 members have been preparing hand sanitizer for first responders by following guidelines set by the World Health Organization.
While the novel coronavirus is well-known for its respiratory effects, a team including BIO5 researcher Dr. Meredith Hay is investigating how the virus impacts the brain.
Made possible by the Technology and Research Initiative Fund (TRIF), the BIO5 Institute solicited COVID-19 research proposals for rapid-turnaround seed grants. Accepted projects address all aspects of the pandemic, including preventions and treatments.
In a rapid response to the pandemic, interdisciplinary teams of two or more principle investigators were encouraged submit applications for basic science, technology, clinical or population research addressing COVID-19. Teams were judged on their abilities to rapidly pivot their research to address the pandemic, cross-disciplinary collaborations and use of core facilities.
In a rapid response to address the pandemic, 13 interdisciplinary teams representing BIO5 and seven UArizona colleges were awarded up to $60K to conduct COVID-related basic science, technology, clinical or population research.
Research, Innovation & Impact is providing up-to-date policy and planning information specific to managing research activities impacted by the coronavirus outbreak. For campus-wide announcements and updates related to COVID-19, please the University of Arizona’s official Coronavirus webpage.
